A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival

Por Botta, C, Di Martino, M T, Ciliberto, D, Cucè, M, Correale, P, Rossi, M, Tagliaferri, P, Tassone, P
Publicado no Blood Cancer J (2016)

Weekly epirubicin in patients with hormone-resistant prostate cancer

Por Petrioli, R, Fiaschi, A I, Pozzessere, D, Messinese, S, Sabatino, M, Marsili, S, Correale, P, Manganelli, A, Salvestrini, F, Francini, G
Publicado em 2002

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response

Por Botta, C, Misso, G, Martino, E C, Pirtoli, L, Cusi, M G, Tassone, P, Tagliaferri, P, Caraglia, M, Correale, P
Publicado no Cell Death Dis (2016)

A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer me...

Por Correale, P, Micheli, L, Vecchio, M T Del, Sabatino, M, Petrioli, R, Pozzessere, D, Marsili, S, Giorgi, G, Lozzi, L, Neri, P, Francini, G
Publicado em 2001

Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation

Por Correale, P, Sciandivasci, A, Intrivici, C, Pascucci, A, Del Vecchio, M T, Marsili, S, Savelli, V, Voltolini, L, Di Bisceglie, M, Guarnieri, A, Gotti, G, Francini, G
Publicado em 2007

In vivo study of the GC90/IRIV vaccine for immune response and autoimmunity into a novel humanised transgenic mouse

Por Scardino, A, Correale, P, Firat, H, Pellegrini, M, Kosmatopoulos, K, Opolon, P, Alves, P, Zurbriggen, R, Glück, R, Lemonnier, F A, Francini, G, Cusi, M G
Publicado em 2003

A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid

Por Correale, P, Messinese, S, Marsili, S, Ceciarini, F, Pozzessere, D, Petrioli, R, Sabatino, M, Cerretani, D, Pellegrini, M, Di Palma, T, Neri, A, Calvanese, A, Pinto, E, Giorgi, G, Francini, G
Publicado em 2003

UFT/leucovorin and oxaliplatin alternated with UFT/leucovorin and irinotecan in metastatic colorectal cancer

Por Petrioli, R, Sabatino, M, Fiaschi, A I, Marsili, S, Pozzessere, D, Messinese, S, Correale, P, Civitelli, S, Tanzini, G, Tani, F, De Martino, A, Marzocca, G, Lorenzi, M, Giorgi, G, Francini, G
Publicado em 2004

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

Por Correale, P, Messinese, S, Caraglia, M, Marsili, S, Piccolomini, A, Petrioli, R, Ceciarini, F, Micheli, L, Nencini, C, Neri, A, Vuolo, G, Guarnieri, A, Abbruzzese, A, Prete, S D, Giorgi, G, Francini, G
Publicado em 2004

Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients

Por Martino, EC, Misso, G, Pastina, P, Costantini, S, Vanni, F, Gandolfo, C, Botta, C, Capone, F, Lombardi, A, Pirtoli, L, Tassone, P, Ulivieri, C, Tagliaferri, P, Cusi, MG, Caraglia, M, Correale, P
Publicado no Cell Death Discov (2016)